BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33232444)

  • 41. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
    Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
    Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi.
    Rodríguez-Hernández KD; Martínez I; Agredano-Moreno LT; Jiménez-García LF; Reyes-Chilpa R; Espinoza B
    Phytomedicine; 2019 Aug; 61():152827. PubMed ID: 31039535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-
    Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities.
    Boechat N; Carvalho AS; Fernandez-Ferreira E; Soares RO; Souza AS; Gibaldi D; Bozza M; Pinto AC
    Cytobios; 2001; 105(409):83-90. PubMed ID: 11393774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
    Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
    Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
    Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
    Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
    Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Fluorinated Phenylbenzothiazole Arrests the Trypanosoma cruzi Cell Cycle and Diminishes the Infection of Mammalian Host Cells.
    Cuevas-Hernández RI; Girard RMBM; Martínez-Cerón S; Santos da Silva M; Elias MC; Crispim M; Trujillo-Ferrara JG; Silber AM
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenothiazinium Dyes Are Active against
    Bulhões Portapilla G; Pereira LM; Bronzon da Costa CM; Voltarelli Providello M; Sampaio Oliveira PA; Goulart A; Ferreira Anchieta N; Wainwright M; Leite Braga GÚ; de Albuquerque S
    Biomed Res Int; 2019; 2019():8301569. PubMed ID: 31355283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).
    Moreno ÉM; Leal SM; Stashenko EE; García LT
    BMC Complement Altern Med; 2018 Jul; 18(1):225. PubMed ID: 30053848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
    Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
    Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
    Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
    Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Betulinic acid induces cell death by necrosis in Trypanosoma cruzi.
    Sousa PL; Souza RODS; Tessarolo LD; de Menezes RRPPB; Sampaio TL; Canuto JA; Martins AMC
    Acta Trop; 2017 Oct; 174():72-75. PubMed ID: 28690148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections.
    Buckner FS
    Adv Exp Med Biol; 2008; 625():61-80. PubMed ID: 18365659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo trypanocidal activity of the ethyl esters of N-allyl and N-propyl oxamates using different Trypanosoma cruzi strains.
    Aguirre-Alvarado C; Zaragoza-Martínez F; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C
    J Enzyme Inhib Med Chem; 2007 Apr; 22(2):227-33. PubMed ID: 17518350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into Chagas treatment based on the potential of bacteriocin AS-48.
    Martín-Escolano R; Cebrián R; Martín-Escolano J; Rosales MJ; Maqueda M; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():1-8. PubMed ID: 30953804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
    Wilkinson SR; Bot C; Kelly JM; Hall BS
    Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.